Renapharma AB is a health care and pharmaceutical startup founded in 2000 by prof. Bo G Danielson. The company's primary focus is on addressing vitamin D deficiency and providing iron supplementation for individuals in Nordic countries. Originally established in Uppsala, Renapharma AB is now headquartered in Stockholm. Despite its commitment to vital healthcare needs, the company does not currently disclose information regarding its last investment or the involved investors.
There is no investment information
No recent news or press coverage available for Renapharma AB.
We care about your data, and we'd love to use cookies make your experience better.
